Skip to content
Sign in

RXL · ARCA · ETF

ProShares Ultra Health Care (RXL) Price, Holdings & Fees

$1,165.71−1.26%−$14.90End-of-day price as of Oct 9, 2026

ProShares Ultra Health Care (RXL) closed at $1,165.71 on Oct 9, 2026, down 1.26% from the previous close of $1,180.61.

Share price, past year

1Y +18.74%

52-week range $944.69 – $1,253.06. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$1,165.71
Sep 30, 2026$1,199.02
Aug 31, 2026$1,231.38
Jul 31, 2026$1,149.13
Jun 30, 2026$1,061.62
May 29, 2026$1,105.82
Apr 30, 2026$1,199.28
Mar 31, 2026$1,121.31
Feb 27, 2026$1,037.52
Jan 30, 2026$973.96
Dec 31, 2025$989.45
Nov 28, 2025$966.65
Oct 31, 2025$987.56

Key statistics

Expense ratio
—
Net assets
$72.1M
as of May 31, 2026
Holdings
70
as of May 31, 2026
52-week range
$944.69 – $1,253.06

Holdings

ProShares Ultra Health Care held 70 investments worth $72.08M as of May 31, 2026. Its largest holding was Eli Lilly & Co., at 12.67% of the fund.

ProShares Ultra Health Care largest holdings by share of net assets
#Holding% of fundValue
1Eli Lilly & Co.12.67%$9.13M
2ProShares GENIUS Money Market ETF11.81%$8.51M
3Johnson & Johnson7.86%$5.66M
4AbbVie, Inc.5.57%$4.01M
5UnitedHealth Group, Inc.4.98%$3.59M
6Merck & Co., Inc.4.26%$3.07M
7Repurchase Agreement2.91%$2.10M
8Thermo Fisher Scientific, Inc.2.68%$1.93M
9Amgen, Inc.2.62%$1.89M
10Gilead Sciences, Inc.2.41%$1.74M
11Intuitive Surgical, Inc.2.18%$1.57M
12Pfizer, Inc.2.15%$1.55M
13Abbott Laboratories2.15%$1.55M
14Repurchase Agreement1.83%$1.32M
15Bristol-Myers Squibb Co.1.68%$1.21M
16CVS Health Corp.1.67%$1.21M
17Danaher Corp.1.66%$1.20M
18Vertex Pharmaceuticals, Inc.1.64%$1.19M
19Stryker Corp.1.52%$1.10M
20Repurchase Agreement1.37%$989.62K
21Medtronic plc1.37%$986.84K
22McKesson Corp.1.32%$948.10K
23Elevance Health, Inc.1.26%$904.73K
24Cigna Group (The)1.06%$762.02K
25Boston Scientific Corp.1.04%$747.07K

Top 25 of 70 holdings, as of May 31, 2026. Percentages are of the fund's net assets.

What the fund owns

ProShares Ultra Health Care holdings by asset type
Asset type% of fund
Stocks78.01%
Other11.81%
Repurchase agreements7.12%
Derivatives−9.72%
ProShares Ultra Health Care holdings by country, largest 2
Country% of fund
United States85.55%
Ireland1.67%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to May 31, 2026, ProShares Ultra Health Care's total return was −13.88%, as reported to the SEC.

ProShares Ultra Health Care monthly total returns
MonthTotal return
May 31, 2026+4.37%
Apr 30, 2026−1.56%
Mar 31, 2026−16.17%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
ProShares Ultra Health Care
Ticker
RXL
Exchange
ARCA
Fund type
ETF
Trust
PROSHARES TRUST
SEC series ID
S000014253
SEC CIK
0001174610
Fractional shares
Yes

Recent SEC filings

Shareholder reports and prospectuses are filed by PROSHARES TRUST, the trust behind ProShares Ultra Health Care, and cover all of its funds.

Frequently asked questions

What is RXL's price?

ProShares Ultra Health Care (RXL) closed at $1,165.71 on Oct 9, 2026, down 1.26% from the previous close of $1,180.61.

What does RXL hold?

ProShares Ultra Health Care held 70 investments worth $72.08M as of May 31, 2026. Its largest holding was Eli Lilly & Co., at 12.67% of the fund. Its five largest holdings were Eli Lilly & Co., ProShares GENIUS Money Market ETF, Johnson & Johnson, AbbVie, Inc., UnitedHealth Group, Inc..

How has RXL performed?

Over the 3 months to May 31, 2026, ProShares Ultra Health Care's total return was −13.88%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of May 31, 2026 (filed Jul 28, 2026). Prices are generated sample data for development. Data sources and disclosures